Questions discussed in this category
For example, do you find trending WBC, procalcitonin, CRP, etc., more or less helpful?
In other words, are there benefits to identifying URI pathogens that do not necessarily have targeted therapies (e.g., rhinovirus, non-COVID-19 Corona...
Do you extend the course of fidaxomicin past initial 10 days to at least 3-7 days after completion of antibiotics?
Would you expect the presence of antibodies to indicate either immunity from contracting the infection, or otherwise risk of transmitting a latent inf...
246792376823173200362383917500
Papers discussed in this category
Microbes and infection, 2024 May 06
The New England journal of medicine, 2023 Aug 17
Thorax, 2009 Oct
The New England journal of medicine, 2013-01-17
Expert opinion on drug safety, 2016 Jan 25